143 related articles for article (PubMed ID: 16158306)
1. Antitumor activity of novel N-sulfonylpyrimidine derivatives on the growth of anaplastic mammary carcinoma in vivo.
Pavlak M; Stojković R; Radacić-Aumiler M; Kasnar-Samprec J; Jercić J; Vlahović K; Zinić B; Radacić M
J Cancer Res Clin Oncol; 2005 Dec; 131(12):829-36. PubMed ID: 16158306
[TBL] [Abstract][Full Text] [Related]
2. Atypical cytostatic mechanism of N-1-sulfonylcytosine derivatives determined by in vitro screening and computational analysis.
Supek F; Kralj M; Marjanović M; Suman L; Smuc T; Krizmanić I; Zinić B
Invest New Drugs; 2008 Apr; 26(2):97-110. PubMed ID: 17898928
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of novel N-1-sulfonylpyrimidine derivatives on human colon carcinoma cells.
Glavas-Obrovac L; Karner I; Stefanić M; Kasnar-Samprec J; Zinić B
Farmaco; 2005; 60(6-7):479-83. PubMed ID: 15913614
[TBL] [Abstract][Full Text] [Related]
4. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Orsolić N; Basić I
Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of water-soluble derivative of propolis and its polyphenolic compounds on tumor growth and metastasizing ability: a possible mode of antitumor action.
Orsolić N; Sver L; Terzić S; Tadić Z; Basić I
Nutr Cancer; 2003; 47(2):156-63. PubMed ID: 15087268
[TBL] [Abstract][Full Text] [Related]
6. Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties.
Sava G; Pacor S; Mestroni G; Alessio E
Clin Exp Metastasis; 1992 Jul; 10(4):273-80. PubMed ID: 1617835
[TBL] [Abstract][Full Text] [Related]
7. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
Milas L; Hersh EM; Stringfellow DA; Hunter N
J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic activity of novel N-1-sulfonypyrimidine derivatives.
Glavas-Obrovac L; Karner I; Zinic B; Pavelic K
Anticancer Res; 2001; 21(3B):1979-86. PubMed ID: 11497287
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
10. Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glands.
Roth DR; Roman D; Cozens R; Brandt R; Seewald W; Greiner B; Wenger F; Mamom T; Germann PG
Exp Toxicol Pathol; 2003 Nov; 55(4):237-45. PubMed ID: 14703768
[TBL] [Abstract][Full Text] [Related]
11. Species differences in troxacitabine pharmacokinetics and pharmacodynamics: implications for clinical development.
Gourdeau H; Leblond L; Hamelin B; Dong K; Ouellet F; Boudreau C; Custeau D; Richard A; Gilbert MJ; Jolivet J
Clin Cancer Res; 2004 Nov; 10(22):7692-702. PubMed ID: 15570003
[TBL] [Abstract][Full Text] [Related]
12. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
Luo FR; Yang Z; Dong H; Camuso A; McGlinchey K; Fager K; Flefleh C; Kan D; Inigo I; Castaneda S; Rose WC; Kramer RA; Wild R; Lee FY
Cancer Chemother Pharmacol; 2005 Nov; 56(5):455-64. PubMed ID: 15947929
[TBL] [Abstract][Full Text] [Related]
13. In vivo toxicity study of N-1-sulfonylcytosine derivatives and their mechanisms of action in cervical carcinoma cell line.
Kašnar-Šamprec J; Ratkaj I; Mišković K; Pavlak M; Baus-Lončar M; Kraljević Pavelić S; Glavaš-Obrovac L; Žinić B
Invest New Drugs; 2012 Jun; 30(3):981-90. PubMed ID: 21424699
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
15. Pyrimidinones: inducers of NK cell activity and antitumor immunity.
Lotzová E; Savary CA
Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):185-91. PubMed ID: 3791954
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
Kadhim SA; Bowlin TL; Waud WR; Angers EG; Bibeau L; DeMuys JM; Bednarski K; Cimpoia A; Attardo G
Cancer Res; 1997 Nov; 57(21):4803-10. PubMed ID: 9354442
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of chemosensitivity against a human breast cancer xenograft (MX-1) with the subrenal capsule assay in BDF1 mice].
Inoue K; Wang Y; Tada A; Ueno K; Kojima K; Ogawa M
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1644-50. PubMed ID: 4026333
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
Menon K; Alvarez E; Forler P; Phares V; Amsrud T; Shih C; Al-Awar R; Teicher BA
Cancer Chemother Pharmacol; 2000; 46(2):142-9. PubMed ID: 10972484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
